Overview

Winner of the 2018 Arthur J. Viseltear Award from the Medical Care Section of the American Public Health Association? Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance-many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children's risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable. Open access edition funded by the National Endowment for the Humanities. The text of this book is licensed under a Creative Commons Attribution NonCommercial-NoDerivatives 4.0 International License: https://creativecommons.org/licenses/by-nc-nd/4.0/

Full Product Details

Author:   Cynthia A Connolly
Publisher:   Rutgers University Press
Imprint:   Rutgers University Press
Dimensions:   Width: 15.20cm , Height: 1.80cm , Length: 22.90cm
Weight:   0.367kg
ISBN:  

9780813563879

ISBN 10:   0813563879
Pages:   260
Publication Date:   11 May 2018
Recommended Age:   From 18 to 99 years
Audience:   College/higher education ,  Professional and scholarly ,  Tertiary & Higher Education ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Reviews

Cynthia Connolly, in this brilliant piece of scholarship, demonstrates not only that drug safety in children has often driven key moments in pharmaceutical regulation, but that issues regarding the logistics, ethics, and market priorities of testing pharmaceuticals in children have evolved and endured for over a century. --Scott Podolsky Harvard Medical School and author of The Antibiotic Era New Scholarly Books: Weekly Book List, June 8, by Nina C. Ayoub--Chronicle of Higher Education This is a succinct, well-organized topical and chronological exploration of child health research and social welfare policy debates and related legislation from the late-19th through the early-21st century. --Choice 'Candy aspirin, ' safety caps, and the history of children's drugs: excerpt of Children and Drug Safety by Cynthia Connolly on Penn Today--Penn Today Making children's medicines tasty makes the experience of being sick less stressful for kids, and helps doctors and parents get kids to take them peacefully. But there is also the danger, if they are too tasty, that kids will consume them in secret, and overdose. Children's aspirin is a stark example of that. St. Joseph Aspirin for Children was released in 1947. It was orange-colored and orange-flavored and often advertised as candy aspirin. And within a few years of its introduction, the incidence of aspirin poisoning in young children increased dramatically, almost five hundred percent, writes Cynthia Connolly, a professor of nursing at the University of Pennsylvania who studies the history of pediatric health care. I, myself, am a former aspirin-poisoned child, Connolly told me. It happened in 1961 or 1962, when she was 3 or 4 years old, she says. My parents kept it up high because they knew I loved it. It had a wonderful granular taste; it tastes like a SweeTart. One time when they weren't looking, I got up there and got the St. Joseph Aspirin for Children, took almost the whole bottle, and then fell off the counter and broke my arm. While still holding the medicine by the way. Her parents found her when she screamed, and she had to go to the hospital and get her stomach pumped--and her arm set. The dangers of candy aspirin led to the development of the safety cap, Connolly writes. And the pharmaceutical industry came to realize that it probably wasn't a great idea to sell medicine as candy. --Julie Beck The Atlantic By exploring the historical context of children and drug therapy, Connolly is the first to link the historiography of pharmaceuticals with the history of childhood and health care. Children and Drug Safety is timely and will make significant contributions to scholarship in the history of health care. --Heather Prescott author of The Morning After: A History of Emergency Contraception in the United States

By exploring the historical context of children and drug therapy, Connolly is the first to link the historiography of pharmaceuticals with the history of childhood and health care. Children and Drug Safety is timely and will make significant contributions to scholarship in the history of health care. --Heather Prescott author of The Morning After: A History of Emergency Contraception in the United States Making children's medicines tasty makes the experience of being sick less stressful for kids, and helps doctors and parents get kids to take them peacefully. But there is also the danger, if they are too tasty, that kids will consume them in secret, and overdose. Children's aspirin is a stark example of that. St. Joseph Aspirin for Children was released in 1947. It was orange-colored and orange-flavored and often advertised as candy aspirin. And within a few years of its introduction, the incidence of aspirin poisoning in young children increased dramatically, almost five hundred percent, writes Cynthia Connolly, a professor of nursing at the University of Pennsylvania who studies the history of pediatric health care. I, myself, am a former aspirin-poisoned child, Connolly told me. It happened in 1961 or 1962, when she was 3 or 4 years old, she says. My parents kept it up high because they knew I loved it. It had a wonderful granular taste; it tastes like a SweeTart. One time when they weren't looking, I got up there and got the St. Joseph Aspirin for Children, took almost the whole bottle, and then fell off the counter and broke my arm. While still holding the medicine by the way. Her parents found her when she screamed, and she had to go to the hospital and get her stomach pumped--and her arm set. The dangers of candy aspirin led to the development of the safety cap, Connolly writes. And the pharmaceutical industry came to realize that it probably wasn't a great idea to sell medicine as candy. --Julie Beck The Atlantic

New Scholarly Books: Weekly Book List, June 8, by Nina C. Ayoub--Chronicle of Higher Education Cynthia Connolly, in this brilliant piece of scholarship, demonstrates not only that drug safety in children has often driven key moments in pharmaceutical regulation, but that issues regarding the logistics, ethics, and market priorities of testing pharmaceuticals in children have evolved and endured for over a century. --Scott Podolsky Harvard Medical School and author of The Antibiotic Era This is a succinct, well-organized topical and chronological exploration of child health research and social welfare policy debates and related legislation from the late-19th through the early-21st century. --Choice 'Candy aspirin, ' safety caps, and the history of children's drugs: excerpt of Children and Drug Safety by Cynthia Connolly on Penn Today--Penn Today Making children's medicines tasty makes the experience of being sick less stressful for kids, and helps doctors and parents get kids to take them peacefully. But there is also the danger, if they are too tasty, that kids will consume them in secret, and overdose. Children's aspirin is a stark example of that. St. Joseph Aspirin for Children was released in 1947. It was orange-colored and orange-flavored and often advertised as candy aspirin. And within a few years of its introduction, the incidence of aspirin poisoning in young children increased dramatically, almost five hundred percent, writes Cynthia Connolly, a professor of nursing at the University of Pennsylvania who studies the history of pediatric health care. I, myself, am a former aspirin-poisoned child, Connolly told me. It happened in 1961 or 1962, when she was 3 or 4 years old, she says. My parents kept it up high because they knew I loved it. It had a wonderful granular taste; it tastes like a SweeTart. One time when they weren't looking, I got up there and got the St. Joseph Aspirin for Children, took almost the whole bottle, and then fell off the counter and broke my arm. While still holding the medicine by the way. Her parents found her when she screamed, and she had to go to the hospital and get her stomach pumped--and her arm set. The dangers of candy aspirin led to the development of the safety cap, Connolly writes. And the pharmaceutical industry came to realize that it probably wasn't a great idea to sell medicine as candy. --Julie Beck The Atlantic By exploring the historical context of children and drug therapy, Connolly is the first to link the historiography of pharmaceuticals with the history of childhood and health care. Children and Drug Safety is timely and will make significant contributions to scholarship in the history of health care. --Heather Prescott author of The Morning After: A History of Emergency Contraception in the United States

Cynthia Connelly, in this brilliant piece of scholarship, demonstrates not only that drug safety in children has often driven key moments in pharmaceutical regulation, but that issues regarding the logistics, ethics, and market priorities of testing pharmaceuticals in children have evolved and endured for over a century. --Scott Podolsky Harvard Medical School and author of The Antibiotic Era Cynthia Connolly, in this brilliant piece of scholarship, demonstrates not only that drug safety in children has often driven key moments in pharmaceutical regulation, but that issues regarding the logistics, ethics, and market priorities of testing pharmaceuticals in children have evolved and endured for over a century. --Scott Podolsky Harvard Medical School and author of The Antibiotic Era By exploring the historical context of children and drug therapy, Connolly is the first to link the historiography of pharmaceuticals with the history of childhood and health care. Children and Drug Safety is timely and will make significant contributions to scholarship in the history of health care. --Heather Prescott author of The Morning After: A History of Emergency Contraception in the United States Making children's medicines tasty makes the experience of being sick less stressful for kids, and helps doctors and parents get kids to take them peacefully. But there is also the danger, if they are too tasty, that kids will consume them in secret, and overdose. Children's aspirin is a stark example of that. St. Joseph Aspirin for Children was released in 1947. It was orange-colored and orange-flavored and often advertised as candy aspirin. And within a few years of its introduction, the incidence of aspirin poisoning in young children increased dramatically, almost five hundred percent, writes Cynthia Connolly, a professor of nursing at the University of Pennsylvania who studies the history of pediatric health care. I, myself, am a former aspirin-poisoned child, Connolly told me. It happened in 1961 or 1962, when she was 3 or 4 years old, she says. My parents kept it up high because they knew I loved it. It had a wonderful granular taste; it tastes like a SweeTart. One time when they weren't looking, I got up there and got the St. Joseph Aspirin for Children, took almost the whole bottle, and then fell off the counter and broke my arm. While still holding the medicine by the way. Her parents found her when she screamed, and she had to go to the hospital and get her stomach pumped--and her arm set. The dangers of candy aspirin led to the development of the safety cap, Connolly writes. And the pharmaceutical industry came to realize that it probably wasn't a great idea to sell medicine as candy. --Julie Beck The Atlantic

Author Information

CYNTHIA A. CONNOLLY is a pediatric nurse and historian of children’s health care. She is an associate professor at the University of Pennsylvania School of Nursing where she is the Rosemarie B. Greco Term Endowed Associate Professor in Advocacy. She is associate director at the Barbara Bates Center for the Study of the History of Nursing, a faculty director at the Field Center for Children’s Policy, Practice, and Research, and a senior fellow at the Leonard Davis Institute of Health Economics, both at the University of Pennsylvania.  She is the author of Saving Sickly Children: The Tuberculosis Preventorium in American Life, 1909–1970 (Rutgers University Press).  

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions